Pharmaceutical Crystals

The crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutic...

Повний опис

Збережено в:
Бібліографічні деталі
Автори: Uekusa, Hidehiro, Yonemochi, Etsuo
Формат: Online
Мова:Англійська
Опубліковано: MDPI - Multidisciplinary Digital Publishing Institute 2021
Предмети:
Онлайн доступ:45988
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
_version_ 1869516031450415104
author Uekusa, Hidehiro
Yonemochi, Etsuo
author_browse Uekusa, Hidehiro
Yonemochi, Etsuo
author_facet Uekusa, Hidehiro
Yonemochi, Etsuo
author_sort Uekusa, Hidehiro
collection Directory of Open Access Books
description The crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. This book entitled “Pharmaceutical Crystals"" focuses on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts, and hydrates, and polymorph crystals are reported. Such crystal structures were investigated in the latest studies that combined morphology, spectroscopic, theoretical calculation, and thermal analysis with crystallographic study. This book highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure–property study of pharmaceutical crystals. The Guest Editors of this book hope the readers enjoy a wide variety of recent studies on Pharmaceutical Crystals.
format Online
id doab-20.500.12854ir-56130
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-561302024-04-05T12:38:51Z Pharmaceutical Crystals Uekusa, Hidehiro Yonemochi, Etsuo QD1-999 Q1-390 QD450-801 crystal structure analysis n/a famotidine solution crystallization salt optimization structure determination from powder diffraction data Hirshfeld surface analysis DFT molecular docking study melting diagram dehydration hygroscopicity HBV Benzodioxole pharmaceutical crystals 4-b]indol-4-one pyrimidin-4(3H)-one liquid assisted grinding HOMO-LUMO dissolution cocrystal formation Raman spectroscopy carbamazepine hydrogen bonding 3 ondansetron physicochemical properties solubility succinic acid cocrystal adefovir dipivoxil hepatitis B polymorphs hydrogen-bond-acceptance ability DFT study Nitrofurantoin–4-dimethylaminopyridine (NF-DMAP) salt photostability on-line monitoring 5-dihydro-4H-pyrimido[5 Imidazole Semicarbazone crystal habit Crystal structure solvent-mediated polymorphic transformation ticagrelor hydrate pharmaceutical cocrystal malonic acid 1H-indole reactivity descriptors famoxadone crystal structure dicarboxylic acid hydrogen bond saccharin thema EDItEUR::P Mathematics and Science::PN Chemistry The crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. This book entitled “Pharmaceutical Crystals"" focuses on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts, and hydrates, and polymorph crystals are reported. Such crystal structures were investigated in the latest studies that combined morphology, spectroscopic, theoretical calculation, and thermal analysis with crystallographic study. This book highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure–property study of pharmaceutical crystals. The Guest Editors of this book hope the readers enjoy a wide variety of recent studies on Pharmaceutical Crystals. 2021-02-11T22:44:34Z 2021-02-11T22:44:34Z 2020-06-09 16:38:57 2020 book 45988 9783039287123 9783039287130 https://directory.doabooks.org/handle/20.500.12854/56130 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/2162 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-03928-713-0 10.3390/books978-3-03928-713-0 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783039287123 9783039287130 148 open access
spellingShingle QD1-999
Q1-390
QD450-801
crystal structure analysis
n/a
famotidine
solution crystallization
salt optimization
structure determination from powder diffraction data
Hirshfeld surface analysis
DFT
molecular docking study
melting diagram
dehydration
hygroscopicity
HBV
Benzodioxole
pharmaceutical crystals
4-b]indol-4-one
pyrimidin-4(3H)-one
liquid assisted grinding
HOMO-LUMO
dissolution
cocrystal formation
Raman spectroscopy
carbamazepine
hydrogen bonding
3
ondansetron
physicochemical properties
solubility
succinic acid
cocrystal
adefovir dipivoxil
hepatitis B
polymorphs
hydrogen-bond-acceptance ability
DFT study
Nitrofurantoin–4-dimethylaminopyridine (NF-DMAP) salt
photostability
on-line monitoring
5-dihydro-4H-pyrimido[5
Imidazole
Semicarbazone
crystal habit
Crystal structure
solvent-mediated polymorphic transformation
ticagrelor
hydrate
pharmaceutical cocrystal
malonic acid
1H-indole
reactivity descriptors
famoxadone
crystal structure
dicarboxylic acid
hydrogen bond
saccharin
thema EDItEUR::P Mathematics and Science::PN Chemistry
Uekusa, Hidehiro
Yonemochi, Etsuo
Pharmaceutical Crystals
title Pharmaceutical Crystals
title_full Pharmaceutical Crystals
title_fullStr Pharmaceutical Crystals
title_full_unstemmed Pharmaceutical Crystals
title_short Pharmaceutical Crystals
title_sort pharmaceutical crystals
topic QD1-999
Q1-390
QD450-801
crystal structure analysis
n/a
famotidine
solution crystallization
salt optimization
structure determination from powder diffraction data
Hirshfeld surface analysis
DFT
molecular docking study
melting diagram
dehydration
hygroscopicity
HBV
Benzodioxole
pharmaceutical crystals
4-b]indol-4-one
pyrimidin-4(3H)-one
liquid assisted grinding
HOMO-LUMO
dissolution
cocrystal formation
Raman spectroscopy
carbamazepine
hydrogen bonding
3
ondansetron
physicochemical properties
solubility
succinic acid
cocrystal
adefovir dipivoxil
hepatitis B
polymorphs
hydrogen-bond-acceptance ability
DFT study
Nitrofurantoin–4-dimethylaminopyridine (NF-DMAP) salt
photostability
on-line monitoring
5-dihydro-4H-pyrimido[5
Imidazole
Semicarbazone
crystal habit
Crystal structure
solvent-mediated polymorphic transformation
ticagrelor
hydrate
pharmaceutical cocrystal
malonic acid
1H-indole
reactivity descriptors
famoxadone
crystal structure
dicarboxylic acid
hydrogen bond
saccharin
thema EDItEUR::P Mathematics and Science::PN Chemistry
topic_facet QD1-999
Q1-390
QD450-801
crystal structure analysis
n/a
famotidine
solution crystallization
salt optimization
structure determination from powder diffraction data
Hirshfeld surface analysis
DFT
molecular docking study
melting diagram
dehydration
hygroscopicity
HBV
Benzodioxole
pharmaceutical crystals
4-b]indol-4-one
pyrimidin-4(3H)-one
liquid assisted grinding
HOMO-LUMO
dissolution
cocrystal formation
Raman spectroscopy
carbamazepine
hydrogen bonding
3
ondansetron
physicochemical properties
solubility
succinic acid
cocrystal
adefovir dipivoxil
hepatitis B
polymorphs
hydrogen-bond-acceptance ability
DFT study
Nitrofurantoin–4-dimethylaminopyridine (NF-DMAP) salt
photostability
on-line monitoring
5-dihydro-4H-pyrimido[5
Imidazole
Semicarbazone
crystal habit
Crystal structure
solvent-mediated polymorphic transformation
ticagrelor
hydrate
pharmaceutical cocrystal
malonic acid
1H-indole
reactivity descriptors
famoxadone
crystal structure
dicarboxylic acid
hydrogen bond
saccharin
thema EDItEUR::P Mathematics and Science::PN Chemistry
url 45988
work_keys_str_mv AT uekusahidehiro pharmaceuticalcrystals
AT yonemochietsuo pharmaceuticalcrystals